Poor Outcomes in Kidney Transplant Candidates and Recipients With History of Falls.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 1 8 2020
pubmed: 1 8 2020
medline: 21 10 2020
Statut: ppublish

Résumé

Falls occur in 28% of hemodialysis patients and increase the risk of physical impairment, morbidity, and mortality. Therefore, it is likely that kidney transplantation (KT) candidates with recurrent falls are less likely to access KT and more likely to experience adverse post-KT outcomes. We used a 2-center cohort study of KT candidates (n = 3666) and recipients (n = 770) (January 2009 to January 2018). Among candidates, we estimated time to listing, waitlist mortality, and transplant rate by recurrent falls (≥2 falls) before evaluation using adjusted regression. Among KT recipients, we estimated risk of mortality, graft loss, and length of stay by recurrent falls before KT using adjusted regression. Candidates with recurrent falls (6.5%) had a lower chance of listing (adjusted hazard ratio [aHR] = 0.68, 95% confidence interval [CI], 0.56-0.83) but not transplant rate; waitlist mortality was 31-fold (95% CI, 11.33-85.93) higher in the first year and gradually decreased over time. Recipients with recurrent falls (5.1%) were at increased risk of mortality (aHR = 51.43, 95% CI, 16.00-165.43) and graft loss (aHR = 33.57, 95% CI, 11.25-100.21) in the first year, which declined over time, and a longer length of stay (adjusted relative ratio [aRR] = 1.13, 95% CI, 1.03-1.25). In summary, 6.5% of KT candidates and 5.1% of recipients experienced recurrent falls which were associated with adverse pre- and post-KT outcomes. While recurrent falls were relatively rare in KT candidates and recipients, they were associated with adverse outcomes. Transplant centers should consider employing fall prevention strategies for high-risk candidates as part of comprehensive prehabilitation.

Sections du résumé

BACKGROUND
Falls occur in 28% of hemodialysis patients and increase the risk of physical impairment, morbidity, and mortality. Therefore, it is likely that kidney transplantation (KT) candidates with recurrent falls are less likely to access KT and more likely to experience adverse post-KT outcomes.
METHODS
We used a 2-center cohort study of KT candidates (n = 3666) and recipients (n = 770) (January 2009 to January 2018). Among candidates, we estimated time to listing, waitlist mortality, and transplant rate by recurrent falls (≥2 falls) before evaluation using adjusted regression. Among KT recipients, we estimated risk of mortality, graft loss, and length of stay by recurrent falls before KT using adjusted regression.
RESULTS
Candidates with recurrent falls (6.5%) had a lower chance of listing (adjusted hazard ratio [aHR] = 0.68, 95% confidence interval [CI], 0.56-0.83) but not transplant rate; waitlist mortality was 31-fold (95% CI, 11.33-85.93) higher in the first year and gradually decreased over time. Recipients with recurrent falls (5.1%) were at increased risk of mortality (aHR = 51.43, 95% CI, 16.00-165.43) and graft loss (aHR = 33.57, 95% CI, 11.25-100.21) in the first year, which declined over time, and a longer length of stay (adjusted relative ratio [aRR] = 1.13, 95% CI, 1.03-1.25). In summary, 6.5% of KT candidates and 5.1% of recipients experienced recurrent falls which were associated with adverse pre- and post-KT outcomes.
CONCLUSIONS
While recurrent falls were relatively rare in KT candidates and recipients, they were associated with adverse outcomes. Transplant centers should consider employing fall prevention strategies for high-risk candidates as part of comprehensive prehabilitation.

Identifiants

pubmed: 32732854
doi: 10.1097/TP.0000000000003057
pii: 00007890-202008000-00036
pmc: PMC7237294
mid: NIHMS1548883
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1738-1745

Subventions

Organisme : NIA NIH HHS
ID : K01 AG064040
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG055781
Pays : United States
Organisme : NIA NIH HHS
ID : F32 AG053025
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK115908
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK101828
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI144954
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK114074
Pays : United States

Références

BMC Nephrol. 2013 Oct 16;14:224
pubmed: 24131569
N Engl J Med. 1997 Oct 30;337(18):1279-84
pubmed: 9345078
Am J Epidemiol. 2013 Aug 1;178(3):418-25
pubmed: 23548756
Am J Kidney Dis. 2003 Jul;42(1):125-32
pubmed: 12830464
Clin Transplant. 2017 Aug;31(8):
pubmed: 28564126
Ann Surg. 2017 Dec;266(6):1084-1090
pubmed: 27655240
Transplantation. 2018 Oct;102(10):1740-1746
pubmed: 29677074
Clin Transplant. 2019 Jan;33(1):e13450
pubmed: 30462375
Nephron Clin Pract. 2011;118(3):c278-84
pubmed: 21212691
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
Transplantation. 2018 Feb;102(2):291-299
pubmed: 28885489
Nephrol Dial Transplant. 2019 Feb 1;34(2):346-354
pubmed: 29868775
J Am Soc Nephrol. 2018 Jun;29(6):1752-1759
pubmed: 29685884
Transplantation. 2017 Oct;101(10):2520-2526
pubmed: 27941434
BMC Nephrol. 2018 Jan 12;19(1):8
pubmed: 29329515
Clin Rehabil. 2006 Apr;20(4):331-9
pubmed: 16719031
Nephrology (Carlton). 2017 Mar;22(3):220-227
pubmed: 26890468
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
JAMA Intern Med. 2013 Oct 28;173(19):1780-6
pubmed: 23958741
BMC Geriatr. 2018 Oct 19;18(1):246
pubmed: 30340462
Am J Transplant. 2018 Jan;18(1):189-196
pubmed: 28710900
Clin J Am Soc Nephrol. 2006 Nov;1(6):1197-204
pubmed: 17699348
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Am J Nephrol. 2015;42(2):134-40
pubmed: 26381744
Am J Transplant. 2019 Feb;19(2):457-465
pubmed: 29962069
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):628-637
pubmed: 29511059

Auteurs

Nadia M Chu (NM)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Zhan Shi (Z)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Rachel Berkowitz (R)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Christine E Haugen (CE)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Jacqueline Garonzik-Wang (J)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Silas P Norman (SP)

Department of Internal Medicine, Division of Nephrology, University of Michigan School of Medicine, Ann Arbor, MI.

Casey Humbyrd (C)

Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Dorry L Segev (DL)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Mara A McAdams-DeMarco (MA)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH